Ian Kulac

6PUBLICATIONS
74CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Epidemiological modellingGene and molecular therapyMajor global burdens of diseaseSexualities
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 28, 2026
Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Results From ACACIA-HCM.

|Sep 05, 2025
Characterization and Application of Novel Exercise Recovery Patterns That Reflect Cardiac Performance: A Substudy of the SEQUOIA-HCM Trial.

Joseph Campain, Catharine Griskowitz, Chloe Newlands

|Sep 28, 2024
Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure.

Muthiah Vaduganathan, Brian L Claggett, Ian J Kulac

|Feb 23, 2024
Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials.

Ankeet S Bhatt, Muthiah Vaduganathan, Brian L Claggett

|Nov 07, 2022
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER.

Xiaowen Wang, Muthiah Vaduganathan, Brian L Claggett

|Aug 27, 2022
Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial.

Alexander Peikert, Felipe A Martinez, Muthiah Vaduganathan

Pageof 1

Frequent Collaborators

5 joint publications

Brian L Claggett

4 joint publications

Sanjiv J Shah

4 joint publications

John J V McMurray

4 joint publications

Muthiah Vaduganathan